XML 37 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash Flows From Operating Activities:    
Net income (loss) $ (287,589) $ 839,866
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 349,375 297,866
Accretion of asset retirement obligation 6,030 0
Common stock issued to directors for services 176,191 0
Deferred income tax expense (benefit) (74,311) 21,926
Change in:    
Accounts receivable, net 946,829 (123,002)
Inventories (387,820) (1,099,035)
Other current assets 250,737 (279,193)
Other assets (100,275) (88,196)
Accounts payable (24,095) 627,752
Accrued payroll, taxes and interest (48,823) (12,302)
Other accrued liabilities (86,858) (36,324)
Deferred revenue (12,092) 0
Payables to related parties (318,596) 28,158
Net cash provided (used) by operating activities 388,703 177,516
Cash Flows From Investing Activities:    
Purchase of certificates of deposit (242,800) (9)
Purchase of properties, plants and equipment (2,292,246) (1,744,892)
Net cash used by investing activities (2,535,046) (1,744,901)
Cash Flows From Financing Activities:    
Net proceeds from (payments to) factor 93,857 497,300
Proceeds from sale of common stock, net of offering costs 4,624,763 1,160,218
Issuance of common stock pursuant to exercise of warrants 60,000 0
Principal payments of long-term debt (147,095) (110,487)
Payments received on stock subscription agreements 0 82,563
Change in checks issued and payable (113,908) 0
Net cash provided by financing activities 4,517,617 1,629,594
NET INCREASE IN CASH AND CASH EQUIVALENTS 2,371,274 62,209
Cash and cash equivalents at beginning of period 5,427 448,861
Cash and cash equivalents at end of period 2,376,701 511,070
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Properties, plants & equipment acquired with long-term debt 352,150 239,900
Properties, plants and equipment acquired with accounts payable 0 89,654
Common stock issued for prepaid directors fees 426,819 0
Common stock issued pursuant to cashless exercise of warrants $ 253 $ 0